Depression, assisted reproductive technology/in vitro fertilization and selective serotonin reuptake inhibitors

Depression, assisted reproductive technology/in vitro fertilization and selective serotonin reuptake inhibitors
In this issue of Fertility and Sterility, Hernandez-Nieto et al. (1) present reassuring data suggesting that in vitro fertilization (IVF) patients exposed to selective serotonin reuptake inhibitors (SSRIs) in vivo are not susceptible to an increased rate of embryo aneuploidy, and that IVF outcomes of patients exposed to SSRIs do not differ from non-exposed patients (1). This reassuring publication is pertinent for many (5%-50%) of the infertile patients undergoing assisted reproductive technology (ART)/IVF, reporting anxiety and depression, many of them need medications, such as SSRI (1).
Source: fertstert.org